Bone
Ewing sarcoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| A-673 |
CVCL_0080
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Breast
Breast adenocarcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| MCF7 |
CVCL_0031
|
Homo sapiens |
0.01uM - 10uM |
6H, 24H |
|
|
|
| MDA-MB-231 |
CVCL_0062
|
Homo sapiens |
0.01uM - 10uM |
24H |
|
|
|
Breast epithelium
Normal
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| MCF-10A |
CVCL_0598
|
Homo sapiens |
0.01uM - 10uM |
24H |
|
|
|
Cervix
Cervical adenocarcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| HeLa |
CVCL_0030
|
Homo sapiens |
0.01uM - 10uM |
24H |
|
|
|
Colon
Colorectal adenocarcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| CL-34 |
CVCL_1123
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| HT-29 |
CVCL_0320
|
Homo sapiens |
0.03uM - 10uM |
6H, 24H |
|
|
|
| LoVo |
CVCL_0399
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| MDST8 |
CVCL_1400
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| NCI-H508 |
CVCL_1561
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| SNU-1040 |
CVCL_5001
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| SNU-C4 |
CVCL_5008
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| SNU-C5 |
CVCL_5009
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| SW480 |
CVCL_0546
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| SW620 |
CVCL_0547
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| SW948 |
CVCL_0550
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Colorectal carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| HCT 116 |
CVCL_0291
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| HT115 |
CVCL_1294
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| RKO |
CVCL_0504
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Endometrium
Endometrial adenocarcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| HEC-108 |
CVCL_2926
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| SNG-M |
CVCL_1707
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Endometrial carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| JHUEM-2 |
CVCL_1327
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Kidney
Normal (Immortalized)
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| HA1E |
CVCL_0284
|
Homo sapiens |
0.01uM - 10uM |
6H, 24H |
|
|
|
Normal (Transformed)
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| 1HAEo- |
CVCL_0128
|
Homo sapiens |
10uM |
24H |
|
|
|
| HEK293 |
CVCL_0045
|
Homo sapiens |
0.01uM - 10uM |
24H |
|
|
|
| NL20 |
CVCL_0461
|
Homo sapiens |
10uM |
24H |
|
|
|
Liver
Hepatoblastoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| Hep G2 |
CVCL_0027
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Lung
Lung adenocarcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| A549 |
CVCL_0023
|
Homo sapiens |
0.01uM - 10uM |
6H, 24H |
|
|
|
| DV-90 |
CVCL_1184
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| SK-LU-1 |
CVCL_0624
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Lung adenosquamous carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| NCI-H596 |
CVCL_1571
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Lung large cell carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| COR-L23 |
CVCL_1133
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| T3M-10 |
CVCL_1729
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Lung squamous cell carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| HCC15 |
CVCL_1253
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Non-small cell lung carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| NCI-H1299 |
CVCL_0060
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| HCC515 |
CVCL_5134
|
Homo sapiens |
0.25uM |
6H, 24H |
|
|
|
| NCI-H2073 |
CVCL_1523
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Normal (Fibroblast)
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| HFL1 |
CVCL_4295
|
Homo sapiens |
10uM |
24H |
|
|
|
| IMR-90 |
CVCL_0347
|
Homo sapiens |
10uM |
24H |
|
|
|
| WI-38 |
CVCL_0579
|
Homo sapiens |
10uM |
24H |
|
|
|
Small cell lung carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| NCI-H1694 |
CVCL_1495
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| NCI-H1836 |
CVCL_1502
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Lymph node
Diffuse large B-cell lymphoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| WSU-DLCL2 |
CVCL_1787
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Ovary
Ovarian carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| EFO-27 |
CVCL_1194
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| OV7 |
CVCL_1623
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Ovarian clear cell carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| RMG-I |
CVCL_1663
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Ovarian mucinous cystadenocarcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| COV644 |
CVCL_2011
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| RMUG-S |
CVCL_1666
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Ovarian undifferentiated carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| TYK-nu |
CVCL_1774
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Pancreas
Pancreatic carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| YAPC |
CVCL_1791
|
Homo sapiens |
0.01uM - 10uM |
24H |
|
|
|
Peripheral blood
Acute monocytic leukemia
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| THP-1 |
CVCL_0006
|
Homo sapiens |
0.04uM - 10uM |
6H, 24H |
|
|
|
Acute myeloid leukemia
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| NOMO-1 |
CVCL_1609
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| PL-21 |
CVCL_2161
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| SKM-1 |
CVCL_0010
|
Homo sapiens |
0.25uM |
6H |
|
|
|
T-cell acute lymphoblastic leukemia
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| Jurkat |
CVCL_0367
|
Homo sapiens |
0.04uM - 10uM |
24H |
|
|
|
Pleural effusion
Histiocytic lymphoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| U-937 |
CVCL_0007
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Prostate
Prostate carcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| 22Rv1 |
CVCL_1045
|
Homo sapiens |
0.66uM - 20uM |
24H |
|
|
|
| C4-2 |
CVCL_4782
|
Homo sapiens |
0.66uM - 20uM |
24H |
|
|
|
| DU 145 |
CVCL_0105
|
Homo sapiens |
0.66uM - 20uM |
24H |
|
|
|
| LNCaP |
CVCL_0395
|
Homo sapiens |
0.66uM - 20uM |
24H |
|
|
|
| PC-3 |
CVCL_0035
|
Homo sapiens |
0.01uM - 20uM |
6H, 24H |
|
|
|
| VCaP |
CVCL_2235
|
Homo sapiens |
0.25uM - 20uM |
6H, 24H |
|
|
|
Skin
Melanoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| A-375 |
CVCL_0132
|
Homo sapiens |
0.01uM - 10uM |
6H, 24H |
|
|
|
| SK-MEL-1 |
CVCL_0523
|
Homo sapiens |
0.25uM |
6H |
|
|
|
| SK-MEL-28 |
CVCL_0526
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Stomach
Gastric adenocarcinoma
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| AGS |
CVCL_0139
|
Homo sapiens |
0.25uM |
6H |
|
|
|
Umbilical vein
Normal
| Cell Line Name |
Cellosaurus Accession |
Species of Origin |
Drug Dosage |
Time Point |
Details |
| HUVEC-C |
CVCL_2959
|
Homo sapiens |
0.04uM - 10uM |
24H |
|
|
|
|